PDI 2009 ISDP LAC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Perit Dial Int 20(6): 742-747 2000
© 2000 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bajo, M.
Right arrow Articles by Corbi, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bajo, M.
Right arrow Articles by Corbi, A
Peritoneal Dialysis International, Vol 20, Issue 6, 742-747
Copyright © 2000 by International Society for Peritoneal Dialysis


Articles

Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo

MA Bajo, R Selgas, MA Castro, G del Peso, C Diaz, JA Sanchez-Tomero, M Fernandez de Castro, V Alvarez, and A Corbi

Servicio de Nefrologia, Hospital Universitario La Paz, Madrid, Spain. mabajo@hulp.insalud.es

OBJECTIVE: To compare the effect of glucose (Glu) and icodextrin (Ico) dialysate on in vitro culture of mesothelial cells (MC) from peritoneal dialysis (PD) patients. DESIGN: Prospective, controlled comparative study on the effects of two PD solutions. SETTING: A tertiary-care public university hospital. PATIENTS: Sixteen PD patients regularly using Glu dialysate were asked to collect an 8-hour dwell peritoneal effluent on 2 different days, with an interval shorter than 7 days. In the first collection, 2.27% Glu solution and in the last, 7.5% Ico solution was infused. Human MC were isolated from the nocturnal peritoneal effluent bags and grown ex vivo. MAIN OUTCOME MEASURES: Mesothelial cell proliferative capacity ex vivo. RESULTS: Mesothelial cells were present in all patient dialysates except that of a single patient's Glu dialysate. The number of MC drained was similar with both solutions. After the initial culture reached confluence, MC were identified in 14 and 12 patients receiving Ico and Glu, respectively. However, in 1 patient using Ico and in 2 using Glu, the MC count at this stage was so low that further subculture could not be performed. Cells from Ico-derived solutions exhibited a higher degree of proliferation than cells from Glu-derived solutions. The morphology of MC was also different. Cells from drained effluent were typical in 11 patients using Glu solution in contrast with 14 patients using Ico. At confluence, the percentages of typical appearance were 50% and 92.9% (p < 0.05) in Glu and Ico respectively. CONCLUSIONS: Mesothelial cells taken from icodextrin effluent show a greater proliferation ex vivo than those taken from glucose effluent.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
A. Vychytil, C. Remon, C. Michel, P. Williams, A. Rodriguez-Carmona, B. Marron, E. Vonesh, S. van der Heyden, J. C. D. Filho, and on behalf of the Extraneal Peritonitis Study Group
Icodextrin does not impact infectious and culture-negative peritonitis rates in peritoneal dialysis patients: a 2-year multicentre, comparative, prospective cohort study
Nephrol. Dial. Transplant., November 1, 2008; 23(11): 3711 - 3719.
[Abstract] [Full Text] [PDF]


Home page
NDT PlusHome page
T. T. Cnossen, C. J. Konings, F. M. van der Sande, K. M. Leunissen, and J. P. Kooman
Clinical effects of icodextrin in peritoneal dialysis
NDT Plus, October 1, 2008; 1(suppl_4): iv18 - iv22.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Endemann, H. Bergmeister, B. Bidmon, M. Boehm, D. Csaicsich, L. Malaga-Dieguez, K. Arbeiter, H. Regele, K. Herkner, and C. Aufricht
Evidence for HSP-mediated cytoskeletal stabilization in mesothelial cells during acute experimental peritoneal dialysis
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F47 - F56.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2000 by Multimed Inc.